Symbols

COCH

Envoy Medical·NASDAQ

--(--)

Signals Analysis

Bullish signal 1

Bearish signal 2

Stock Price Surged Significantly

Negative Gross Margin

Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About COCH

Envoy Medical, Inc.

A company that has been engaged in the production and sales of implantable hearing aids for many years

Industry

Healthcare Equipment and Supplies

Established Date

Listing Date

04/29/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.envoymedical.com

Security Type

Common stock

Office address

4875 White Bear Parkway, White Bear Lake, MN 55110

Business

Introduction

Envoy Medical, Inc., is incorporated in Delaware. The company is a hearing health company focused on Innovative Medical technologies for the hearing loss spectrum. It developed the Esteem FI-AMEI, the only fully implantable active hearing aid implant approved by the FDA, and is currently advancing the Acclaim CI cochlear implant project under study with its sensor technology.

Company Financials

EPS

COCH has released its 2025 Q4 earnings. EPS was reported at -0.27, versus the expected -0.2, missing expectations. The chart below visualizes how COCH has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

COCH has released its 2025 Q4 earnings report, with revenue of 75.00K, reflecting a YoY change of 78.57%, and net profit of -6.59M, showing a YoY change of -42.62%. The Sankey diagram below clearly presents COCH's revenue sources and cost distribution.